Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

DiaSorin S.p.A (DIA) - Financial and Strategic SWOT Analysis Review

DiaSorinS.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. The company offers products grouped under two segments, namely, immunodiagnostics, and molecular diagnostics. Its key products offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA) under immunediagnosticssegment; and extraction, amplification, and diagnostic products under molecular diagnostics segment.

DiaSorin S.p.A Key Recent Developments

Mar 14, 2014: Sorin Group Announces Final Financial Results for 2013
Jan 24, 2014: DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in China
Nov 08, 2013: The board of directors approves the Q3'13 results
Aug 01, 2013: The Board of Directors approves the results for the H1 '13
Jul 24, 2013: DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM

Change Currency


Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency


Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.


Contrast settings

Text size settings